Us Bancorp \De\ Neoleukin Therapeutics, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.5 - $0.72 $11,673 - $16,809	23,346 Added 111.17%	44,346 $31,000
Q2 2022 Aug 01, 2022	BUY	$0.92 - $2.25 $9,200 - $22,500	10,000 Added 90.91%	21,000 $22,000
Q1 2022 May 11, 2022	BUY	$1.72 - $5.23 $18,920 - $57,530	11,000 New	11,000 $21,000
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.75 $762 - $1,271	-164 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$6.05 - $9.66 $992 - $1,584	164 New	164 $1,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.